Topical treatments for diabetic neuropathic pain (Review)
- Authors:
- Xi‑Ding Yang
- Ping‑Fei Fang
- Da‑Xiong Xiang
- Yong‑Yu Yang
-
Affiliations: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China - Published online on: January 15, 2019 https://doi.org/10.3892/etm.2019.7173
- Pages: 1963-1976
-
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
International Diabetes Federation (IDF). IDF Diabetes Atlas (7th). 2017. | |
|
Edwards JL, Vincent AM, Cheng HT and Feldman EL: Diabetic neuropathy: Mechanisms to management. Pharmacol Ther. 120:1–34. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Harati Y: Diabetic neuropathies: Unanswered questions. Neurol Clin. 25:303–317. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Farmer KL, Li C and Dobrowsky RT: Diabetic peripheral neuropathy: Should a chaperone accompany our therapeutic approach? Pharmacol Rev. 64:880–900. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Spallone V, Lacerenza M, Rossi A, Sicuteri R and Marchettini P: Painful diabetic polyneuropathy: Approach to diagnosis and management. Clin J Pain. 28:726–743. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Snyder MJ, Gibbs LM and Lindsay TJ: Treating painful diabetic peripheral neuropathy: An update. Am Fam Physician. 94:227–234. 2016.PubMed/NCBI | |
|
Schreiber AK, Nones CF, Reis RC, Chichorro JG and Cunha JM: Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 6:432–444. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI and Boulton AJ: Toronto Expert Panel on Diabetic Neuropathy: Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 27:629–638. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jane SW, Lin MS, Chiu WN, Beaton RD and Chen MY: Prevalence, discomfort and self-relief behaviours of painful diabetic neuropathy in Taiwan: A cross-sectional study. BMJ Open. 6:e118972016. View Article : Google Scholar | |
|
Tesfaye S, Boulton AJ and Dickenson AH: Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 36:2456–2465. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS and Stacey B: Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 30:374–385. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, Garrow A, Waterman C, Cavanagh PR and Boulton AJ: Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care. 28:2378–2383. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sadosky A, McDermott AM, Brandenburg NA and Strauss M: A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 8:45–56. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ziegler D: Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metab Res Rev. 24 Suppl 1:S52–S57. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kaku M, Vinik A and Simpson DM: Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep. 15:6092015. View Article : Google Scholar : PubMed/NCBI | |
|
Sawynok J and Zinger C: Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain. Expert Opin Pharmacother. 17:601–609. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ziegler D and Fonseca V: From guideline to patient: A review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J Diabetes Complications. 29:146–156. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
van Nooten F, Treur M, Pantiri K, Stoker M and Charokopou M: Capsaicin 8% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: A systematic literature review and network meta-analysis. Clin Ther. 39:787–803.e18. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Argoff CE: Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 88:195–205. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jorge LL, Feres CC and Teles VE: Topical preparations for pain relief: Efficacy and patient adherence. J Pain Res. 4:11–24. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Derry S, Rice AS, Cole P, Tan T and Moore RA: Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 1:CD0073932017.PubMed/NCBI | |
|
Mick G and Correa-Illanes G: Topical pain management with the 5% lidocaine medicated plaster-a review. Curr Med Res Opin. 28:937–951. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M and Katz NP: Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain. 30:286–294. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kiani J, Ahmad Nasrollahi S, Esna-Ashari F, Fallah P and Sajedi F: Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety). Iran J Pharm Res. 14:1263–1268. 2015.PubMed/NCBI | |
|
Wrzosek A, Woron J, Dobrogowski J, Jakowicka-Wordliczek J and Wordliczek J: Topical clonidine for neuropathic pain. Cochrane Database Syst Rev. 8:CD0109672015.PubMed/NCBI | |
|
Motilal S and Maharaj RG: Nutmeg extracts for painful diabetic neuropathy: A randomized, double-blind, controlled study. J Altern Complement Med. 19:347–352. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Heydari M, Homayouni K, Hashempur MH and Shams M: Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial. J Diabetes. 8:246–252. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
A study of the efficacy and safety of amitriptyline/ketamine topical cream in patients with diabetic peripheral neuropathy. simpleClinicalTrials.govNCT00476151. 2006 | |
|
Casale R, Symeonidou Z and Bartolo M: Topical treatments for localized neuropathic pain. Curr Pain Headache Rep. 21:152017. View Article : Google Scholar : PubMed/NCBI | |
|
Sloan G, Shillo P, Selvarajah D, Wu J, Wilkinson ID, Tracey I, Anand P and Tesfaye S: A new look at painful diabetic neuropathy. Diabetes Res Clin Pract. 144:177–191. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dewanjee S, Das S, Das AK, Bhattacharjee N, Dihingia A, Dua TK, Kalita J and Manna P: Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol. 833:472–523. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dobretsov M, Hastings SL, Romanovsky D, Stimers JR and Zhang JM: Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 960:174–183. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Oyibo SO, Prasad YD, Jackson NJ, Jude EB and Boulton AJ: The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: A pilot study. Diabet Med. 19:870–873. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Morley GK, Mooradian AD, Levine AS and Morley JE: Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med. 77:79–82. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Cox DJ, Mook DG and McCarty RC: Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain. 40:105–107. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA and O'Brien PC: Variables influencing neuropathic endpoints: The rochester diabetic neuropathy study of healthy subjects. Neurology. 45:1115–1121. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Romanovsky D, Wang J, Al-Chaer ED, Stimers JR and Dobretsov M: Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopenia. Neuroscience. 170:337–347. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Peppa M, Stavroulakis P and Raptis SA: Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 17:461–472. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Babizhayev MA, Strokov IA, Nosikov VV, Savel'Yeva EL, Sitnikov VF, Yegorov YE and Lankin VZ: The role of oxidative stress in diabetic neuropathy: Generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type i diabetic patients. Cell Biochem Biophys. 71:1425–1443. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Oates PJ: Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 50:325–392. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Obrosova IG: How does glucose generate oxidative stress in peripheral nerve Int Rev Neurobiol. 50:3–35. 2002.PubMed/NCBI | |
|
Obrosova IG: Diabetes and the peripheral nerve. Biochim Biophys Acta. 1792:931–940. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schemmel KE, Padiyara RS and D'Souza JJ: Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: A review. J Diabetes Complications. 24:354–360. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Fuchs D, Birklein F, Reeh PW and Sauer SK: Sensitized peripheral nociception in experimental diabetes of the rat. Pain. 151:496–505. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bachewal P, Gundu C, Yerra VG, Kalvala AK, Areti A and Kumar A: Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors. 44:109–122. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tobon-Velasco JC, Cuevas E and Torres-Ramos MA: Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 13:1615–1626. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gao X, Wu B, Fu Z, Zhang Z and Xu G: Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells. Eur J Pharmacol. 814:144–150. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dworkin RH: An overview of neuropathic pain: Syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 18:343–349. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Djouhri L, Fang X, Koutsikou S and Lawson SN: Partial nerve injury induces electrophysiological changes in conducting (uninjured) nociceptive and nonnociceptive DRG neurons: Possible relationships to aspects of peripheral neuropathic pain and paresthesias. Pain. 153:1824–1836. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Aslam A, Singh J and Rajbhandari S: Pathogenesis of painful diabetic neuropathy. Pain Res Treat. 2014:4120412014.PubMed/NCBI | |
|
Rahman MH, Jha MK and Suk K: Evolving insights into the pathophysiology of diabetic neuropathy: Implications of malfunctioning glia and discovery of novel therapeutic targets. Curr Pharm Des. 22:738–757. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I and Serpell M: 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 25:1663–1676. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Krumova EK, Zeller M, Westermann A and Maier C: Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers. Pain. 153:273–280. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J and Dworkin RH: An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med. 6:379–384. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Argoff CE, Galer BS, Jensen MP, Oleka N and Gammaitoni AR: Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: Assessment with the neuropathic pain scale. Curr Med Res Opin. 20 Suppl 2:S21–S28. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA and Dworkin RH: Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 61:914–918. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Devers A and Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: An open-label study. Clin J Pain. 16:205–208. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wolff RF, Bala MM, Westwood M, Kessels AG and Kleijnen J: 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): A systematic review. Swiss Med Wkly. 140:297–306. 2010.PubMed/NCBI | |
|
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I and Serpell M: Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: Interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig. 29:231–241. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I and Serpell M: Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 25:1677–1687. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
White WT, Patel N, Drass M and Nalamachu S: Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain. Pain Med. 4:321–330. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ho KY, Huh BK, White WD, Yeh CC and Miller EJ: Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 24:51–55. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng J, Zheng S, Feng Q, Zhang Q and Xiao X: Dietary capsaicin and its anti-obesity potency: From mechanism to clinical implications. Biosci Rep. 37(pii): BSR20170286. 2017. | |
|
Musharraf MU, Ahmad Z and Yaqub Z: Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy. J Ayub Med Coll Abbottabad. 29:384–387. 2017.PubMed/NCBI | |
|
Mitchell K, Bates BD, Keller JM, Lopez M, Scholl L, Navarro J, Madian N, Haspel G, Nemenov MI and Iadarola MJ: Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: Analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol Pain. 6:942010. View Article : Google Scholar : PubMed/NCBI | |
|
Fattori V, Hohmann MS, Rossaneis AC, Pinho-Ribeiro FA and Verri WA: Capsaicin: Current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules. 21(pii): E8442016. View Article : Google Scholar : PubMed/NCBI | |
|
What role for capsaicin in diabetic peripheral neuropathy? Drug Ther Bull. 54:90–93. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rosenberg CJ and Watson JC: Treatment of painful diabetic peripheral neuropathy. Prosthet Orthot Int. 39:17–28. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch Intern Med. 151:2225–2229. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. The Capsaicin Study Group. Diabetes Care. 15:159–165. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, Ward WK and Bernstein JE: A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther. 12:111–120. 1995.PubMed/NCBI | |
|
Tandan R, Lewis GA, Badger GB and Fries TJ: Topical capsaicin in painful diabetic neuropathy. Effect on sensory function. Diabetes Care. 15:15–18. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Tandan R, Lewis GA, Krusinski PB, Badger GB and Fries TJ: Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up. Diabetes Care. 15:8–14. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E and Tarsy D: Does capsaicin relieve the pain of diabetic neuropathy? Pain. 42:387–388. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Kulkantrakorn K, Lorsuwansiri C and Meesawatsom P: 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial. Pain Pract. 13:497–503. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B and Katz N: Capsaicin 8% patch in painful diabetic peripheral neuropathy: A randomized, double-blind, placebo-controlled study. J Pain. 18:42–53. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E and Katz N: Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: A randomised, 52-week, open-label, safety study. BMC Neurol. 16:2512016. View Article : Google Scholar : PubMed/NCBI | |
|
Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, et al: Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine and the American academy of physical medicine and rehabilitation. PM R. 3:345–352. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pancrazio JJ, Kamatchi GL, Roscoe AK and Lynch CR III: Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 284:208–214. 1998.PubMed/NCBI | |
|
Nicholson GM, Blanche T, Mansfield K and Tran Y: Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs. Eur J Pharmacol. 452:35–48. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Joshi PG, Singh A and Ravichandra B: High concentrations of tricyclic antidepressants increase intracellular Ca2+ in cultured neural cells. Neurochem Res. 24:391–398. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Watson CP: The treatment of neuropathic pain: Antidepressants and opioids. Clin J Pain. 16 (2 Suppl):S49–S55. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Kopsky DJ and Hesselink JM: High doses of topical amitriptyline in neuropathic pain: Two cases and literature review. Pain Pract. 12:148–153. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zeraatian S, Zakeri H, Boroojeny SB, Hourang MH, Ghaffarpasand F and Fard MM: Effect of oral clonidine on acute intraocular pressure rise after phacoemulsification: A prospective double-blind, randomized, clinical trial. J Ocul Pharmacol Ther. 27:293–297. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Otasowie J, Castells X, Ehimare UP and Smith CH: Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 9:CD0069972014. | |
|
Sawynok J: Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development. Eur J Pain. 18:465–481. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Campbell C, Campbell J, Schmidt W, Brady K and Stouch B: Topical clonidine gel reduces pain caused by diabetic neuropathy: Results of a multicenter, placebo-controlled clinical trial. J Pain. 10 Suppl:S552009. View Article : Google Scholar | |
|
Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, Petersen KL, Rowbotham MC and Campbell JN: Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain. 153:1815–1823. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Grover JK, Khandkar S, Vats V, Dhunnoo Y and Das D: Pharmacological studies on myristica fragrans-antidiarrheal, hypnotic, analgesic and hemodynamic (blood pressure) parameters. Methods Find Exp Clin Pharmacol. 24:675–680. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hayfaa AA, Sahar AM and Awatif MA: Evaluation of analgesic activity and toxicity of alkaloids in myristica fragrans seeds in mice. J Pain Res. 6:611–615. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Forouzanfar F and Hosseinzadeh H: Medicinal herbs in the treatment of neuropathic pain: A review. Iran J Basic Med Sci. 21:347–358. 2018.PubMed/NCBI | |
|
Ramanathan T, Gurudeeban S and Satyavani K: Local anesthetic effect of citrullus colocynthis on rana hexadactyla. Res J Med Plant. 5:338–342. 2011. View Article : Google Scholar | |
|
Kumar S, Kumar D, Manjusha, Saroha K, Singh N and Vashishta B: Antioxidant and free radical scavenging potential of citrullus colocynthis (L.) schrad. Methanolic fruit extract. Acta Pharm. 58:215–220. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy VP, Sudheshna G, Shaik A, Saran SS, Kumar SN, Ram CR and Reddy KR: Evaluation of antiulcer activity of Citrullus colocynthis fruit against pylorus ligation induced ulcers in male Wistar rats. Int J Pharm Pharm Sci. 4:446–451. 2012. | |
|
Nedjat S, Montazeri A, Holakouie K, Mohammad K and Majdzadeh R: Psychometric properties of the Iranian interview-administered version of the world health organization's quality of life questionnaire (WHOQOL-BREF): A population-based study. BMC Health Serv Res. 8:612008. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch ME, Clark AJ, Sawynok J and Sullivan MJ: Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial. Anesthesiology. 103:140–146. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hocking G and Cousins MJ: Ketamine in chronic pain management: An evidence-based review. Anesth Analg. 97:1730–1739. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Niesters M, Martini C and Dahan A: Ketamine for chronic pain: Risks and benefits. Br J Clin Pharmacol. 77:357–367. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mion G and Villevieille T: Ketamine pharmacology: An update (pharmacodynamics and molecular aspects, recent findings). Cns Neurosci Ther. 19:370–380. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mahoney JM, Vardaxis V, Moore JL, Hall AM, Haffner KE and Peterson MC: Topical ketamine cream in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled, double-blind initial study. J Am Podiatr Med Assoc. 102:178–183. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch ME, Clark AJ and Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 19:323–328. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch ME, Clark AJ, Sawynok J and Sullivan MJ: Topical amitriptyline and ketamine in neuropathic pain syndromes: An open-label study. J Pain. 6:644–649. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Somberg JC and Molnar J: Retrospective study on the analgesic activity of a topical (TT-CTAC) cream in patients with diabetic neuropathy and other chronic pain conditions. Am J Ther. 22:214–221. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Javed S, Petropoulos IN, Alam U and Malik RA: Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 6:15–28. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Stanos SP and Galluzzi KE: Topical therapies in the management of chronic pain. Postgrad Med. 125 (4 Suppl):S25–S33. 2013. View Article : Google Scholar | |
|
Barkin RL: The pharmacology of topical analgesics. Postgrad Med. 125 (4 Suppl 1):S7–S18. 2013. View Article : Google Scholar | |
|
Pickering G, Martin E, Tiberghien F, Delorme C and Mick G: Localized neuropathic pain: An expert consensus on local treatments. Drug Des Devel Ther. 11:2709–2718. 2017. View Article : Google Scholar : PubMed/NCBI |
